(Q36821859)

16 August 2017

1 reference

title

Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines (English)

1 reference

16 August 2017

Wakeling AE

1

1 reference

16 August 2017

Barker AJ

2

1 reference

16 August 2017

Davies DH

3

1 reference

16 August 2017

Brown DS

4

1 reference

16 August 2017

Green LR

5

1 reference

16 August 2017

Cartlidge SA

6

1 reference

16 August 2017

Woodburn JR

7

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

16 August 2017

7

1 reference

Breast Cancer Research and Treatment

inferred from page(s)

published in

1 reference

16 August 2017

38

1 reference

16 August 2017

67-73

1 reference

16 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01803785

16 August 2017

0 references

cites work

Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.

1 reference

12 December 2020

Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens

1 reference

12 December 2020

RETRACTED: 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity

1 reference

12 December 2020

Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells

1 reference

12 December 2020

Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth

1 reference

12 December 2020

The EGF receptor system as a target for antitumor therapy

1 reference

12 December 2020

Tyrphostins--potential antiproliferative agents and novel molecular tools

1 reference

12 December 2020

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

1 reference

12 December 2020

Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer

1 reference

12 December 2020

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

12 December 2020

The type I growth factor receptors in human breast cancer

1 reference

12 December 2020

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor

1 reference

12 December 2020

Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids).

1 reference

12 December 2020

The unliganded estrogen receptor (ER) transduces growth factor signals

1 reference

12 December 2020

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

1 reference

12 December 2020

The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice

1 reference

12 December 2020

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

12 December 2020

How receptor tyrosine kinases activate Ras.

1 reference

12 December 2020

Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins

1 reference

12 December 2020

Kinetic model of the epidermal growth factor (EGF) receptor tyrosine kinase and a possible mechanism of its activation by EGF

1 reference

12 December 2020

Growth factor receptor tyrosine kinases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01803785

1 reference

16 August 2017

1 reference